• News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
logo
  • News
    • News
    • Upcoming Events
    • Subscribe
  • Our Company
    • Our Story
    • Our Vision
    • Board of Directors
    • Alzinova Team
    • Advisers & Collaborators
  • Patients & Families
    • Alzheimer's Patients
    • Impact on Society
    • The Unmet Medical Need
  • R & D
    • Alzheimer's Disease
    • Our Programs
    • Specific Targeting of Toxic Aβ Oligomers
    • The AβCC Peptide™ Technology
    • Scientific Presentations
  • Investors
    • Overview
    • News
    • Analyses
    • Press Releases
      • English
      • Swedish
      • Subscribe
    • Presentations
    • Board and Management
    • The Share
    • Financial Reports
      • Financial Reports - English
      • Financial Reports – Swedish
      • Financial Calendar
    • Corporate Governance
    • General Meetings
    • IR Contact
  • Career
  • Contact
Home / Investors / The Share / Analyst Coverage
  • Overview
  • Analyses
  • Press Releases
    • English
    • Swedish
    • Subscribe
  • Presentations
  • Board and Management
  • The Share
  • Financial Reports
    • Financial Reports - English
    • Financial Reports – Swedish
    • Financial Calendar
  • Corporate Governance
  • General Meetings
  • IR Contact

Analyst Coverage

 

Carnegie Investment Bank AB
Maria Karlsson Osipova, Securities – Equity Research
Phone: +46 762 74 41 13
E-mail: maria.karlsson.osipova@carnegie.se

Company site at Carnegie Investment Bank

Analysis 21 November 2023 (Swedish) View pdf 

Analysis 21 November 2023 (English). View pdf 

 

Redeye Equity Research
Kevin Sule, Analyst
Phone: +46 720 92 18 87
E-mail: kevin.sule@redeye.se

Company site at Redeye

Analysis December 2023. View pdf

Analysis February 2023. View pdf

Analysis June 2022. View  pdf

Analysis November 2021. View pdf

Analysis January 2019. View pdf

 

Additional Equity Research by Mangold

Analysis 22 March 2023. View pdf

Analysis 12 October 2022. View pdf

Analysis 2 June 2022. View pdf

Analysis 26 January 2022. View pdf

 

Additional Equity Research by Carlsquare

Analysis in Swedish 

  • News
  • Our Company
  • Patients & Families
  • R & D
  • Investors
  • Contact

Alzinova AB, Gemenskapens gata 9,  SE-431 53 Mölndal
info@alzinova.com

Follow us on

follow us on linkedin